Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis

NCT05371964

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Irvine, California, United States
  • University of Miami Coral Gables, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details
Active, not recruiting

Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia

NCT00070499

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, BCR-ABL1 Positive, +11 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 340 locations
View Trial Details
Active, not recruiting

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

NCT02475681

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Goodyear, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Anaheim, California, United States
  • Research Site Los Angeles, California, United States
View all 155 locations
View Trial Details
Active, not recruiting

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

NCT05761171

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 84 locations
View Trial Details
Active, not recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

NCT04084080

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama Tuscaloosa, Alabama, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Howard University Center for Sickle Cell Disease Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, not recruiting

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

NCT05353647

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View Trial Details

Related conditions